461 related articles for article (PubMed ID: 23263788)
1. Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease.
Poth JM; Brodsky K; Ehrentraut H; Grenz A; Eltzschig HK
J Mol Med (Berl); 2013 Feb; 91(2):183-93. PubMed ID: 23263788
[TBL] [Abstract][Full Text] [Related]
2. Alternative adenosine Receptor activation: The netrin-Adora2b link.
Yuan X; Mills T; Doursout MF; Evans SE; Vidal Melo MF; Eltzschig HK
Front Pharmacol; 2022; 13():944994. PubMed ID: 35910389
[TBL] [Abstract][Full Text] [Related]
3. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation.
Eltzschig HK; Rivera-Nieves J; Colgan SP
Expert Opin Ther Targets; 2009 Nov; 13(11):1267-77. PubMed ID: 19769545
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia signaling during intestinal ischemia and inflammation.
Grenz A; Clambey E; Eltzschig HK
Curr Opin Crit Care; 2012 Apr; 18(2):178-85. PubMed ID: 22322265
[TBL] [Abstract][Full Text] [Related]
5. The Hypoxia-Adenosine Link during Myocardial Ischemia-Reperfusion Injury.
Ruan W; Ma X; Bang IH; Liang Y; Muehlschlegel JD; Tsai KL; Mills TW; Yuan X; Eltzschig HK
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009485
[TBL] [Abstract][Full Text] [Related]
6. The hypoxia-adenosine link during inflammation.
Bowser JL; Lee JW; Yuan X; Eltzschig HK
J Appl Physiol (1985); 2017 Nov; 123(5):1303-1320. PubMed ID: 28798196
[TBL] [Abstract][Full Text] [Related]
7. Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury.
Li X; Berg NK; Mills T; Zhang K; Eltzschig HK; Yuan X
Front Immunol; 2020; 11():604944. PubMed ID: 33519814
[TBL] [Abstract][Full Text] [Related]
8. Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury.
Eckle T; Kewley EM; Brodsky KS; Tak E; Bonney S; Gobel M; Anderson D; Glover LE; Riegel AK; Colgan SP; Eltzschig HK
J Immunol; 2014 Feb; 192(3):1249-56. PubMed ID: 24391213
[TBL] [Abstract][Full Text] [Related]
9. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
Shohet RV; Garcia JA
J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
[TBL] [Abstract][Full Text] [Related]
10. Interplay of hypoxia and A2B adenosine receptors in tissue protection.
Koeppen M; Eckle T; Eltzschig HK
Adv Pharmacol; 2011; 61():145-86. PubMed ID: 21586359
[TBL] [Abstract][Full Text] [Related]
11. The stimulatory adenosine receptor ADORA2B regulates serotonin (5-HT) synthesis and release in oxygen-depleted EC cells in inflammatory bowel disease.
Dammen R; Haugen M; Svejda B; Alaimo D; Brenna O; Pfragner R; Gustafsson BI; Kidd M
PLoS One; 2013; 8(4):e62607. PubMed ID: 23638125
[TBL] [Abstract][Full Text] [Related]
12. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process.
Ortiz-Masià D; Díez I; Calatayud S; Hernández C; Cosín-Roger J; Hinojosa J; Esplugues JV; Barrachina MD
PLoS One; 2012; 7(10):e48535. PubMed ID: 23119050
[TBL] [Abstract][Full Text] [Related]
13. Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.
Zimmerman MA; Grenz A; Tak E; Kaplan M; Ridyard D; Brodsky KS; Mandell MS; Kam I; Eltzschig HK
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):12012-7. PubMed ID: 23812746
[TBL] [Abstract][Full Text] [Related]
14. Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.
Colgan SP; Eltzschig HK
Annu Rev Physiol; 2012; 74():153-75. PubMed ID: 21942704
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal upregulation of hypoxia-inducible factor-1α and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia.
Iriyama T; Wang W; Parchim NF; Sayama S; Kumasawa K; Nagamatsu T; Song A; Xia Y; Kellems RE
FASEB J; 2020 Mar; 34(3):4041-4054. PubMed ID: 31930569
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A(2)A receptor but not HIF-1 mediates Tyrosine hydroxylase induction in hypoxic PC12 cells.
Gammella E; Cairo G; Tacchini L
J Neurosci Res; 2010 Jul; 88(9):2007-16. PubMed ID: 20143408
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia.
Morote-Garcia JC; Rosenberger P; Nivillac NM; Coe IR; Eltzschig HK
Gastroenterology; 2009 Feb; 136(2):607-18. PubMed ID: 19105964
[TBL] [Abstract][Full Text] [Related]
18. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
Strickland LN; Faraoni EY; Ruan W; Yuan X; Eltzschig HK; Bailey-Lundberg JM
Front Immunol; 2023; 14():1163585. PubMed ID: 37187740
[TBL] [Abstract][Full Text] [Related]
19. Attenuating myocardial ischemia by targeting A2B adenosine receptors.
Eltzschig HK; Bonney SK; Eckle T
Trends Mol Med; 2013 Jun; 19(6):345-54. PubMed ID: 23540714
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-dependent activation of hypoxia-inducible factor-1 induces late preconditioning in liver cells.
Alchera E; Tacchini L; Imarisio C; Dal Ponte C; De Ponti C; Gammella E; Cairo G; Albano E; Carini R
Hepatology; 2008 Jul; 48(1):230-9. PubMed ID: 18506850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
